Hyperkalemia risk with finerenone in diabetic kidney disease: a real-world analysis from the FINE-TURK cohort.

Özdede M, Yadigar S, Güven AT, Akgür S, Arslan F, Sezen M, Özcan B, Ayaz EY, Doğantekin B, Atay İ, Değer SM, Demir M, Koyuncu S, Yılmaz Ü, İnci A, Çolak H, Demirelli B, Tuğlular S, Oguz EG, Ayli MD, Avanaz E, Yılmaz F, Doğan B, Karaköse S, Karakan MŞ, Demirci BG, Türkmen K, Baloğlu İ, Batmazoğlu M, Mert M, Aydın E, Aydın FY, Parmaksız E, Özdemir P, Ediz B, Aydın Z, Demir ME, Sezer S, Ünver S, Baykal Ö, Akman B, Altuntaş A, İslam M, Koçak SY, Mert M, Dursun B, Eren N, Demir SB, Bilgiç MA, Erdut A, Keskin G, Horoz M, Şahin AZ, Tekinyıldız M, Duranay M, Yalın SF, Umut HMY, Altunok M, Sarı R, Sarı F, Torun D, Kahvecioğlu S, Karatutlu AS, Akagün T, Çelik H, Kazan S, Öztürk İ, Polat M, Aydın MF, Meşe M, Demirezen A, Derici Ü, Altun E, Bakırdöğen S, Kara E, Akgöl C, Aykent MB, İlter A, Ekmekci A, Ulu S, Arıcı M, Şengül E, Bakır EA

Open source

DOI: 10.1093/ckj/sfag227
Published: 2026 Aug
Container: Clinical kidney journal
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1093/ckj/sfag227,
  title = {Hyperkalemia risk with finerenone in diabetic kidney disease: a real-world analysis from the FINE-TURK cohort.},
  author = {Özdede M and Yadigar S and Güven AT and Akgür S and Arslan F and Sezen M and Özcan B and Ayaz EY and Doğantekin B and Atay İ and Değer SM and Demir M and Koyuncu S and Yılmaz Ü and İnci A and Çolak H and Demirelli B and Tuğlular S and Oguz EG and Ayli MD and Avanaz E and Yılmaz F and Doğan B and Karaköse S and Karakan MŞ and Demirci BG and Türkmen K and Baloğlu İ and Batmazoğlu M and Mert M and Aydın E and Aydın FY and Parmaksız E and Özdemir P and Ediz B and Aydın Z and Demir ME and Sezer S and Ünver S and Baykal Ö and Akman B and Altuntaş A and İslam M and Koçak SY and Mert M and Dursun B and Eren N and Demir SB and Bilgiç MA and Erdut A and Keskin G and Horoz M and Şahin AZ and Tekinyıldız M and Duranay M and Yalın SF and Umut HMY and Altunok M and Sarı R and Sarı F and Torun D and Kahvecioğlu S and Karatutlu AS and Akagün T and Çelik H and Kazan S and Öztürk İ and Polat M and Aydın MF and Meşe M and Demirezen A and Derici Ü and Altun E and Bakırdöğen S and Kara E and Akgöl C and Aykent MB and İlter A and Ekmekci A and Ulu S and Arıcı M and Şengül E and Bakır EA},
  year = {2026},
  journal = {Clinical kidney journal},
  doi = {10.1093/ckj/sfag227},
  url = {https://doi.org/10.1093/ckj/sfag227}
}

RIS

TY  - JOUR
TI  - Hyperkalemia risk with finerenone in diabetic kidney disease: a real-world analysis from the FINE-TURK cohort.
AU  - Özdede M
AU  - Yadigar S
AU  - Güven AT
AU  - Akgür S
AU  - Arslan F
AU  - Sezen M
AU  - Özcan B
AU  - Ayaz EY
AU  - Doğantekin B
AU  - Atay İ
AU  - Değer SM
AU  - Demir M
AU  - Koyuncu S
AU  - Yılmaz Ü
AU  - İnci A
AU  - Çolak H
AU  - Demirelli B
AU  - Tuğlular S
AU  - Oguz EG
AU  - Ayli MD
AU  - Avanaz E
AU  - Yılmaz F
AU  - Doğan B
AU  - Karaköse S
AU  - Karakan MŞ
AU  - Demirci BG
AU  - Türkmen K
AU  - Baloğlu İ
AU  - Batmazoğlu M
AU  - Mert M
AU  - Aydın E
AU  - Aydın FY
AU  - Parmaksız E
AU  - Özdemir P
AU  - Ediz B
AU  - Aydın Z
AU  - Demir ME
AU  - Sezer S
AU  - Ünver S
AU  - Baykal Ö
AU  - Akman B
AU  - Altuntaş A
AU  - İslam M
AU  - Koçak SY
AU  - Mert M
AU  - Dursun B
AU  - Eren N
AU  - Demir SB
AU  - Bilgiç MA
AU  - Erdut A
AU  - Keskin G
AU  - Horoz M
AU  - Şahin AZ
AU  - Tekinyıldız M
AU  - Duranay M
AU  - Yalın SF
AU  - Umut HMY
AU  - Altunok M
AU  - Sarı R
AU  - Sarı F
AU  - Torun D
AU  - Kahvecioğlu S
AU  - Karatutlu AS
AU  - Akagün T
AU  - Çelik H
AU  - Kazan S
AU  - Öztürk İ
AU  - Polat M
AU  - Aydın MF
AU  - Meşe M
AU  - Demirezen A
AU  - Derici Ü
AU  - Altun E
AU  - Bakırdöğen S
AU  - Kara E
AU  - Akgöl C
AU  - Aykent MB
AU  - İlter A
AU  - Ekmekci A
AU  - Ulu S
AU  - Arıcı M
AU  - Şengül E
AU  - Bakır EA
PY  - 2026
JO  - Clinical kidney journal
DO  - 10.1093/ckj/sfag227
UR  - https://doi.org/10.1093/ckj/sfag227
ER  -

APA

M, Ö., S, Y., AT, G., S, A., F, A., M, S., B, Ö., EY, A., B, D., İ, A., SM, D., M, D., S, K., Ü, Y., A, İ., H, Ç., B, D., S, T., EG, O., MD, A., E, A., F, Y., B, D., S, K., MŞ, K., BG, D., K, T., İ, B., M, B., M, M., E, A., FY, A., E, P., P, Ö., B, E., Z, A., ME, D., S, S., S, Ü., Ö, B., B, A., A, A., M, İ., SY, K., M, M., B, D., N, E., SB, D., MA, B., A, E., G, K., M, H., AZ, Ş., M, T., M, D., SF, Y., HMY, U., M, A., R, S., F, S., D, T., S, K., AS, K., T, A., H, Ç., S, K., İ, Ö., M, P., MF, A., M, M., A, D., Ü, D., E, A., S, B., E, K., C, A., MB, A., A, İ., A, E., S, U., M, A., E, Ş., & EA, B. (2026). Hyperkalemia risk with finerenone in diabetic kidney disease: a real-world analysis from the FINE-TURK cohort.. Clinical kidney journal. https://doi.org/10.1093/ckj/sfag227

Source records

pubmed · retrieved 2026-09-25T23:31:30.824Z